Neuehealth Reports Third Quarter 2024 Results

NEUE Stock   4.86  0.14  2.80%   
About 66% of NeueHealth's investor base is looking to short. The analysis of overall sentiment of trading NeueHealth stock suggests that many investors are alarmed at this time. The current market sentiment, together with NeueHealth's historical and current headlines, can help investors time the market. In addition, many technical investors use NeueHealth stock news signals to limit their universe of possible portfolio assets.
  
NeueHealth, Inc. , the value-driven healthcare company, today reported financial results for its third qua

Read at businesswire.com
businesswire News
  

NeueHealth Fundamental Analysis

We analyze NeueHealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeueHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeueHealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

NeueHealth is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

NeueHealth Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeueHealth stock to make a market-neutral strategy. Peer analysis of NeueHealth could also be used in its relative valuation, which is a method of valuing NeueHealth by comparing valuation metrics with similar companies.

Complementary Tools for NeueHealth Stock analysis

When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments